The mRNA industry experienced a new wave of innovation, with the development of cancer vaccines, emerging therapeutics, and novel gene editing tools. Yet, the speed, cost of production, and limited flexibility to improve current processes remained a significant challenge that hindered and slowed the development of these promising therapeutics.

Over three days, we took a deep dive into these obstacles. The summit was carefully designed to help implement high-throughput process development, optimize mRNA synthesis and purification, develop process analytics and optimize drug product formulation which unlocked the unlimited potential of mRNA for all applications.